• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-term proton pump inhibitors use and risk of gastric cancer: a meta-analysis of 926 386 participants.

作者信息

Wan Qian-Yi, Wu Xiao-Ting, Li Ni, Du Liang, Zhou Yong

机构信息

Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China.

Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Gut. 2019 Apr;68(4):762-764. doi: 10.1136/gutjnl-2018-316416. Epub 2018 Apr 3.

DOI:10.1136/gutjnl-2018-316416
PMID:29615489
Abstract
摘要

相似文献

1
Long-term proton pump inhibitors use and risk of gastric cancer: a meta-analysis of 926 386 participants.长期使用质子泵抑制剂与胃癌风险：对926386名参与者的荟萃分析
Gut. 2019 Apr;68(4):762-764. doi: 10.1136/gutjnl-2018-316416. Epub 2018 Apr 3.
2
Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for : a retrospective cohort analysis.长期使用质子泵抑制剂是治疗后患胃癌的一个风险因素：一项回顾性队列分析。
Gut. 2018 Oct;67(10):1908-1910. doi: 10.1136/gutjnl-2017-315710. Epub 2017 Dec 22.
3
Long-term proton pump inhibitor use after eradication may create a gastric environment for -nitrosamine formation and gastric cancer development.根除幽门螺杆菌后长期使用质子泵抑制剂可能会为亚硝胺的形成和胃癌的发展创造一个胃部环境。
Gut. 2019 Jun;68(6):1131. doi: 10.1136/gutjnl-2018-316592. Epub 2018 May 25.
4
eradication failure may have confounded the recent large-scale health database study that showed proton pump inhibitors increase gastric cancer risk.根除治疗失败可能混淆了近期一项大规模健康数据库研究的结果，该研究显示质子泵抑制剂会增加胃癌风险。
Gut. 2018 Nov;67(11):2071-2072. doi: 10.1136/gutjnl-2017-315698. Epub 2017 Dec 15.
5
Proton pump inhibitors and gastric cancer: association is not causation.质子泵抑制剂与胃癌：有关联但并非因果关系。
Gut. 2019 Aug;68(8):1529-1530. doi: 10.1136/gutjnl-2018-316958. Epub 2018 Jul 13.
6
Proton pump inhibitors and risk of gastric cancer in a case-control study.一项病例对照研究中的质子泵抑制剂与胃癌风险
Gut. 2019 Apr;68(4):765-767. doi: 10.1136/gutjnl-2018-316371. Epub 2018 Apr 16.
7
Risk factors for gastric cancer: is it time to discard PPIs?胃癌的危险因素：是时候摒弃质子泵抑制剂了吗？
Gut. 2019 Jan;68(1):176-177. doi: 10.1136/gutjnl-2017-315621. Epub 2018 Jan 13.
8
Proton pump inhibitors and risk for gastric cancer: Is it real?质子泵抑制剂与胃癌风险：这是真的吗？
Turk J Gastroenterol. 2019 Mar;30(3):309-310. doi: 10.5152/tjg.2019.18674.
9
OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer.OLGIM分期和质子泵抑制剂的使用可预测胃癌风险。
Gut. 2022 May;71(5):1043-1044. doi: 10.1136/gutjnl-2021-325551. Epub 2021 Aug 3.
10
Rationale for a Helicobacter pylori Test and Treatment Strategy in Gastroesophageal Reflux Disease.胃食管反流病中幽门螺杆菌检测与治疗策略的理论依据
Gastroenterol Clin North Am. 2015 Sep;44(3):661-6. doi: 10.1016/j.gtc.2015.05.007. Epub 2015 Jun 19.

引用本文的文献

1
Risk factors for gastric cancer: an umbrella review of systematic reviews and meta-analyses.胃癌的危险因素：系统评价和荟萃分析的伞状综述
Front Oncol. 2025 Jun 26;15:1564575. doi: 10.3389/fonc.2025.1564575. eCollection 2025.
2
Proton pump inhibitors and the risk of gastric cancer: a systematic review, evidence synthesis and life course epidemiology perspective.质子泵抑制剂与胃癌风险：一项系统综述、证据综合及生命历程流行病学视角分析
BMJ Open Gastroenterol. 2025 Apr 19;12(1):e001719. doi: 10.1136/bmjgast-2024-001719.
3
Effects of the Transcutaneous Electrical Stimulation System on Heartburn, Regurgitation and Esophageal Acid Exposure in GERD Patients-An Uncontrolled Feasibility Study.
经皮电刺激系统对胃食管反流病患者烧心、反流及食管酸暴露的影响——一项非对照可行性研究
Neurogastroenterol Motil. 2025 May;37(5):e15002. doi: 10.1111/nmo.15002. Epub 2025 Jan 23.
4
Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro-Oesophageal Reflux Disease or Erosive Oesophagitis.沃克索拉唑治疗症状性胃食管反流病或糜烂性食管炎安全性的综合分析
Aliment Pharmacol Ther. 2025 Mar;61(5):835-851. doi: 10.1111/apt.18458. Epub 2024 Dec 25.
5
Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors.与长期使用质子泵抑制剂相关的不良反应。
Chonnam Med J. 2023 May;59(2):115-127. doi: 10.4068/cmj.2023.59.2.115. Epub 2023 May 25.
6
Current management of gastro-oesophageal reflux disease-treatment costs, safety profile, and effectiveness: a narrative review.胃食管反流病的当前管理——治疗成本、安全性和有效性：一项叙述性综述
Gastroenterol Rep (Oxf). 2023 Apr 18;11:goad008. doi: 10.1093/gastro/goad008. eCollection 2023.
7
Exposure to Commonly Used Drugs and the Risk of Gastric Cancer: An Umbrella Review of Meta-Analyses.常用药物暴露与胃癌风险：一项Meta分析的伞形综述
Cancers (Basel). 2023 Jan 6;15(2):372. doi: 10.3390/cancers15020372.
8
Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals.质子泵抑制剂的使用与胰腺癌风险：来自11项流行病学研究的证据，涉及150万人。
Cancers (Basel). 2022 Oct 30;14(21):5357. doi: 10.3390/cancers14215357.
9
Sex and smoking differences in the association between gastroesophageal reflux and risk of esophageal squamous cell carcinoma in a high-incidence area: Golestan Cohort Study.高发地区食管胃反流与食管鳞癌风险相关性的性别和吸烟差异：戈勒斯坦队列研究。
Int J Cancer. 2023 Mar 15;152(6):1137-1149. doi: 10.1002/ijc.34313. Epub 2022 Nov 1.
10
Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal.质子泵抑制剂的使用与胃癌风险：来自流行病学研究的当前证据及批判性评价
Cancers (Basel). 2022 Jun 21;14(13):3052. doi: 10.3390/cancers14133052.